Pediatric kidney transplantation: A review

Transplant Research and Risk Management

Volumn 5, Issue , 2013, Pages 21-31

  Sharma, Amit ^a   Ramanathan, Rajesh ^a   Posner, Marc ^a   Fisher, Robert A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Dialysis; End stage renal disease; Immunosuppression; Organ donors; Pediatric kidney transplantation

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ATROPHY; CADAVER DONOR; CARDIOVASCULAR DISEASE; CHILD; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FIBROSING ALVEOLITIS; FOCAL GLOMERULOSCLEROSIS; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT THROMBOSIS; GROWTH DISORDER; HEALTH CARE POLICY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY MALFORMATION; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MAINTENANCE THERAPY; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; OBSTRUCTIVE UROPATHY; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; REVIEW; RISK FACTOR; THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; TUBULAR ATROPHY; URINARY TRACT DISEASE;

EID: 84880301034     PISSN: None     EISSN: 11791616     Source Type: Journal    
DOI: 10.2147/TRRM.S34043     Document Type: Review

References (116)

1. Starzl T, Marchioro T, Porter K. The role of the organ transplantation in pediatrics. Pediatr Clin North Am. 1966;13:381-422.
2. North American Pediatric Renal Trials and Collaborative Studies. NAPRTCS 2010 Annual Transplant Report. Available from: https://web.emmes.com/study/ped/annlrept/2010_Report.pdf. Accessed April 3, 2013.
3. US Renal Data System. USRDS 2009 annual data report: atlas of end-stage renal disease in the United States, National Institutes Of Health. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2009. Available from: http://www.usrds.org/atlas09.aspx. Accessed May 23, 2013.
4. Moudgil A. Primer on renal transplantation. Indian J Pediatr. 2012;79: 1076-1083.
5. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.11 Paediatrics (specific problems). Nephrol Dial Transplant. 2002;17 Suppl 4:55-58.
6. United States Organ Transplantation. OPTN and SRTR annual data report 2011. Available from: http://srtr.transplant.hrsa.gov/annual_reports/2011/pdf/00_intro_12.pdf. Accessed May 23, 2013.
7. Chava SP, Singh B, Pal S, Dhawan A, Heaton ND. Indications for combined liver and kidney transplantation in children. Pediatr Transplant. 2009;13:661-669.
8. Gagnadoux MF, Lacaille F, Niaudet P, et al. Long term results of liver-kidney transplantation in children with primary hyperoxaluria. Pediatr Nephrol. 2001;16:946-950.
9. Jamieson NV; European PHI Transplantation Study Group. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 Transplant Registry experience 1984-2004. Am J Nephrol. 2005;25:282-289.
10. Millan MT, Berquist WE, So SK, et al. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation. 2003;76:1458-1463.
11. Simpson N, Cho YW, Cicciarelli JC, Selby RR, Fong TL. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS database. Transplantation. 2006;82:1298-1303.
12. Smith JM, Martz K, Blydt-Hansen TD. Pediatric kidney transplant practice patterns and outcome benchmarks, 1987-2010: a report of the North American Pediatric Renal Trials and Collaborative Studies. Pediatr Transplant. 2013;17:149-157.
13. Amaral S, Patzer RE, Kutner N, McClellan W. Racial disparities in access to pediatric kidney transplantation since Share 35. J Am Soc Nephrol. 2012;23:1069-1077.
14. Agarwal S, Oak N, Siddique J, Harland RC, Abbo ED. Changes in pediatric renal transplantation after implementation of the revised deceased donor kidney allocation policy. Am J Transplant. 2009;9:1237-1242.
15. Moudgil A, Dharnidharka VR, Lamb KE, Meier-Kriesche HU. Best allograft survival from Share-35 kidney donors occurs in middle-aged adults and young children - an analysis of OPTN data. Transplantation. 2013;95:319-325.
16. Pascual J, Zamora J, Galeano C, Royuela A, Quereda C. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev. 2009;1:CD005632.
17. Gallinat A, Sotiropoulos GC, Witzke O, et al. Kidney grafts from donors,/=5 yr of age: single kidney transplantation for pediatric recipients or en bloc transplantation for adults? Pediatr Transplant. 2013;17:179-184.
18. Butani L, Troppmann C, Perez RV. Outcomes of children receiving en bloc renal transplants from small pediatric donors. Pediatr Transplant. 2013;17:55-58.
19. Sharma A, Fisher RA, Cotterell AH, King AL, Maluf DG, Posner MP. En bloc kidney transplantation from pediatric donors: comparable outcomes with living donor kidney transplantation. Transplantation. 2011;92:564-569.
20. Sharma A, Ramanathan R, Behnke M, Fisher R, Posner M. Single pediatric kidney transplantation in adult recipients: comparable outcomes with standard-criteria deceased-donor kidney transplantation. Transplantation. March 26, 2013. [Epub ahead of print.]
21. Fonseca-Aten M, Michaels MG. Infections in pediatric solid organ transplant recipients. Semin Pediatr Surg. 2006;15:153-161.
22. Eneriz-Wiemer M, Sarwal M, Donovan D, Costaglio C, Concepcion W, Salvatierra O Jr. Successful renal transplantation in high-risk small children with a completely thrombosed inferior vena cava. Transplantation. 2006;82:1148-1152.
23. Salvatierra O Jr, Concepcion W, Sarwal MM. Renal transplantation in children with thrombosis of the inferior vena cava requires careful assessment and planning. Pediatr Nephrol. 2008;23:2107-2109.
24. Ghane Sharbaf F, Bitzan M, Szymanski KM, et al. Native nephrectomy prior to pediatric kidney transplantation: biological and clinical aspects. Pediatr Nephrol. 2012;27:1179-1188.
25. Dharamsi N, Sheldon C, Goebel J. Kidney transplantation. In: Docimo S, Canning D, Khoury A, editors. The Kelalis-King-Belman Textbook of Clinical Pediatric Urology, 5th ed. New York, NY: Taylor and Francis; 2006.
26. Sarwal M, Pascual J. Immunosuppression minimization in pediatric transplantation. Am J Transplant. 2007;7:2227-2235.
27. Shapiro R, Sarwal MM. Pediatric kidney transplantation. Pediatr Clin North Am. 2010;57:393-400.
28. Vo AA, Lukovsky M, Toyoda M, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med. 2008;359:242-251.
29. Valentini RP, Nehlsen-Cannarella SL, Gruber SA, et al. Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients. Pediatr Transplant. 2007;11:77-81.
30. Connolly JA, Miller B, Bretan PN. Renal transplantation in patients with posterior urethral valves: favorable long-term outcome. J Urol. 1995;154:1153-1155.
31. Fontaine E, Salomon L, Gagnadoux MF, Niaudet P, Broyer M, Beurton D. Long-term results of renal transplantation in children with the prune-belly syndrome. J Urol. 1997;158(3 Pt 1):892-894.
32. Otukesh H, Sharifian M, Simfroosh N, et al. Outcome of renal transplantation in children with low urinary tract abnormality. Transplant Proc. 2005;37:3071-3074.
33. Salomon L, Fontaine E, Gagnadoux MF, Broyer M, Beurton D. Posterior urethral valves: long-term renal function consequences after transplantation. J Urol. 1997;157:992-995.
34. Adams J, Mehls O, Wiesel M. Pediatric renal transplantation and the dysfunctional bladder. Transpl Int. 2004;17:596-602.
35. Taghizadeh AK, Desai D, Ledermann SE, et al. Renal transplantation or bladder augmentation first? A comparison of complications and outcomes in children. BJU Int. 2007;100:1365-1370.
36. Riley P, Marks SD, Desai DY, Mushtaq I, Koffman G, Mamode N. Challenges facing renal transplantation in pediatric patients with lower urinary tract dysfunction. Transplantation. 2010;89:1299-1307.
37. Theodorou C, Kostakis A, Bokos J, Plastiras D, Vosnides G. Lower urinary tract reconstruction in association with renal transplantation. Int Urol Nephrol. 1997;29:695-699.
38. Mitchell ME. Bladder augmentation in children: where have we been and where are we going? BJU Int. 2003;92 Suppl 1:29-34.
39. Landau EH, Jayanthi VR, McLorie GA, Churchill BM, Khoury AE. Renal transplantation in children following augmentation ureterocystoplasty. Urology. 1997;50:260-262.
40. Hatch DA. Kidney transplantation in patients with an abnormal lower urinary tract. Urol Clin North Am. 1994;21:311-320.
41. Salvatierra O Jr, Sarwal M, Alexander S, et al. A new, unique and simple method for ureteral implantation in kidney recipients with small, defunctionalized bladders. Transplantation. 1999;68:731-738.
42. Salvatierra O Jr, Millan M, Concepcion W. Pediatric renal transplantation with considerations for successful outcomes. Semin Pediatr Surg. 2006;15:208-217.
43. Salvatierra O Jr, Singh T, Shifrin R, et al. Successful transplantation of adult-sized kidneys into infants requires maintenance of high aortic blood flow. Transplantation. 1998;66:819-823.
44. Swiatecka-Urban A, Garcia C, Feuerstein D, et al. Basiliximab induction improves the outcome of renal transplants in children and adolescents. Pediatr Nephrol. 2001;16:693-696.
45. Offner G, Broyer M, Niaudet P, et al. A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients. Transplantation. 2002;74:961-966.
46. Pape L, Strehlau J, Henne T, et al. Single centre experience with basiliximab in paediatric renal transplantation. Nephrol Dial Transplant. 2002;17:276-280.
47. Grenda R, Watson A, Vondrak K, et al. A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. Am J Transplant. 2006;6:1666-1672.
48. Webb NJ, Prokurat S, Vondrak K, et al. Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data. Pediatr Nephrol. 2009;24:177-182.
49. Kari JA, Trompeter RS. What is the calcineurin inhibitor of choice for pediatric renal transplantation? Pediatr Transplant. 2004;8:437-444.
50. Knoll GA, Bell RC. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ. 1999;318:1104-1107.
51. Margreiter R; European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet. 2002;359:741-746.
52. Mayer AD, Dmitrewski J, Squifflet JP, et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation. 1997;64:436-443.
53. Trompeter R, Fitzpatrick M, Hutchinson C, Johnston A. Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion (Neoral) in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption. Pediatr Transplant. 2003;7:282-288.
54. Harmon W, Meyers K, Ingelfinger J, et al. Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renaltransplantation. J Am Soc Nephrol. 2006;17:1735-1745.
55. Weintraub L, Li L, Kambham N, et al. Patient selection critical for calcineurin inhibitor withdrawal in pediatric kidney transplantation. Pediatr Transplant. 2008;12:541-549.
56. Silverstein DM, Aviles DH, LeBlanc PM, Jung FF, Vehaskari VM. Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients. Pediatr Transplant. 2005;9: 589-597.
57. Sutherland S, Li L, Concepcion W, Salvatierra O, Sarwal MM. Steroid-free immunosuppression in pediatric renal transplantation: rationale for and [corrected] outcomes following conversion to steroid based therapy. Transplantation. 2009;87:1744-1748.
58. Benfield MR, Bartosh S, Ikle D, et al. A randomized double-blind, placebo controlled trial of steroid withdrawal after pediatric renal transplantation. Am J Transplant. 2010;10:81-88.
59. Delucchi A, Valenzuela M, Ferrario M, et al. Early steroid withdrawal in pediatric renal transplant on newer immunosuppressive drugs. Pediatr Transplant. 2007;11:743-748.
60. Hocker B, Tonshoff B. Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview. Paediatr Drugs. 2009;11:381-396.
61. Hamiwka LA, Burns A, Bell L. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data. Pediatr Transplant. 2006;10:337-344.
62. Jensen S, Jackson EC, Riley L, Reddy S, Goebel J. Tacrolimus-based immunosuppression with steroid withdrawal in pediatric kidney transplantation - 4-year experience at a moderate-volume center. Pediatr Transplant. 2003;7:119-124.
63. Li L, Chang A, Naesens M, et al. Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits. Am J Transplant. 2009;9:1362-1372.
64. Chavers BM, Chang YC, Gillingham KJ, Matas A. Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results. Transplantation. 2009;88:237-241.
65. Gulati A, Sarwal MM. Pediatric renal transplantation: an overview and update. Curr Opin Pediatr. 2010;22:189-196.
66. Birk PE, Stannard KM, Konrad HB, et al. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Pediatr Transplant. 2004;8:29-38.
67. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003;349:125-138.
68. Gargah T, Abidi K, Rajhi H, Ben Abdallah T, Chebil M, Lakhoua MR. Vascular complications after pediatric kidney transplantation. Tunis Med. 2011;89:458-461.
69. Keller AK, Jorgensen TM, Jespersen B. Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature. J Transplant. 2012;2012:793461.
70. Afanetti M, Niaudet P, Niel O, Saint Faust M, Cochat P, Berard E. Pediatric en bloc kidney transplantation into pediatric recipients: the French experience. Pediatr Transplant. 2012;16:183-186.
71. Ismail H, Kalicinski P, Drewniak T, et al. Primary vascular thrombosis after renal transplantation in children. Pediatr Transplant. 1997;1: 43-47.
72. Kamel MH, Mohan P, Conlon PJ, Little DM, O'Kelly P, Hickey DP. Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft thrombosis. Pediatr Transplant. 2006;10:816-821.
73. van Lieburg AF, de Jong MC, Hoitsma AJ, Buskens FG, Schroder CH, Monnens LA. Renal transplant thrombosis in children. J Pediatr Surg. 1995;30:615-619.
74. Mickelson JJ, MacNeily AE, Leblanc J, White C, Gourlay WA. Renal transplantation in children 15 kg or less: the British Columbia Children's Hospital experience. J Urol. 2006;176(4 Pt 2):1797-1800.
75. Kranz B, Vester U, Nadalin S, Paul A, Broelsch CE, Hoyer PF. Outcome after kidney transplantation in children with thrombotic risk factors. Pediatr Transplant. 2006;10:788-793.
76. Chu WP. Ultrasonography diagnosis of renal arterial thrombosis: an important cause of renal allograft loss in children. Hong Kong Med J. 2011;17:421-422.
77. Routh JC, Yu RN, Kozinn SI, Nguyen HT, Borer JG. Urological complications and vesicoureteral reflux following pediatric kidney transplantation. J Urol. 2013;189:1071-1076.
78. Nuininga JE, Feitz WF, van Dael KC, de Gier RP, Cornelissen EA. Urological complications in pediatric renal transplantation. Eur Urol. 2001;39:598-602.
79. Dalgic A, Boyvat F, Karakayali H, Moray G, Emiroglu R, Haberal M. Urologic complications in 1523 renal transplantations: the Baskent University experience. Transplant Proc. 2006;38:543-547.
80. Englesbe MJ, Lynch RJ, Heidt DG, et al. Early urologic complicationsafter pediatric renal transplant: a single-center experience. Transplantation. 2008;86:1560-1564.
81. Khositseth S, Askiti V, Nevins TE, et al. Increased urologic complications in children after kidney transplants for obstructive and reflux uropathy. Am J Transplant. 2007;7:2152-2157.
82. Alam S, Sheldon C. Urological issues in pediatric renal transplantation. Curr Opin Urol. 2008;18:413-418.
83. Barrero R, Fijo J, Fernandez-Hurtado M, Garcia-Merino F, Leon E, Torrubia F. Vesicoureteral reflux after kidney transplantation in children. Pediatr Transplant. 2007;11:498-503.
84. Allain-Launay E, Roussey-Kesler G, Ranchin B, et al. Mortality in pediatric renal transplantation: a study of the French Pediatric Kidney database. Pediatr Transplant. 2009;13:725-730.
85. Li L, Chaudhuri A, Weintraub LA, et al. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant. 2007;11: 187-195.
86. Kranz B, Vester U, Wingen AM, et al. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection. Pediatr Transplant. 2008;12:474-478.
87. Smith JM, Corey L, Bittner R, et al. Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation. J Am Soc Nephrol. 2010;21:1579-1586.
88. Al Khasawneh E, Araya CE, Dharnidharka VR. Missed viral surveillance testing visits associate with full blown viral diseases in children receiving kidney transplants. Pediatr Transplant. 2013;17: 129-132.
89. Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol. 2007;2:1037-1042.
90. Fogeda M, Munoz P, Luque A, Morales MD, Bouza E; BKV Study Group. Cross-sectional study of BK virus infection in pediatric kidney transplant recipients. Pediatr Transplant. 2007;11:394-401.
91. Dharnidharka VR, Abdulnour HA, Araya CE. The BK virus in renal transplant recipients - review of pathogenesis, diagnosis, and treatment. Pediatr Nephrol. 2011;26:1763-1774.
92. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199:837-846.
93. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80(Suppl 2):S254-S264.
94. McDonald RA, Smith JM, Ho M, et al. Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant. 2008;8:984-989.
95. Swinnen LJ, Fisher RI. OKT3 monoclonal antibodies induce interleukin-6 and interleukin-10: a possible cause of lymphoproliferative disorders associated with transplantation. Curr Opin Nephrol Hypertens. 1993;2:670-678.
96. Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation. 2003;76:1289-1293.
97. Cleper R, Ben Shalom E, Landau D, et al. Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study. Pediatr Transplant. 2012;16:619-626.
98. Grenda R, Webb NJ. Steroid minimization in pediatric renal transplantation: early withdrawal or avoidance? Pediatr Transplant. 2010;14:961-967.
99. Kauffman HM, Cherikh WS, Cheng Y, Hanto DW, Kahan BD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation. 2005;80:883-889.
100. Nepomuceno RR, Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. Cancer Res. 2003;63:4472-4480.
101. Green M, Michaels MG, Webber SA, Rowe D, Reyes J. The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Pediatr Transplant. 1999;3:271-281.
102. Dharnidharka VR, Araya CE. Post-transplant lymphoproliferative disease. Pediatr Nephrol. 2009;24:731-736.
103. Choquet S, Leblond V, Herbrecht R, et al. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood. 2006;107: 3053-3057.
104. Ghobrial IM, Habermann TM, Ristow KM, et al. Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era. Leuk Lymphoma. 2005;46:191-196.
105. Shaw RJ, Palmer L, Blasey C, Sarwal M. A typology of non-adherence in pediatric renal transplant recipients. Pediatr Transplant. 2003;7: 489-493.
106. Koshy SM, Hebert D, Lam K, Stukel TA, Guttmann A. Renal allograft loss during transition to adult healthcare services among pediatric renal transplant patients. Transplantation. 2009;87:1733-1736.
107. Zarkhin V, Kambham N, Li L, et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int. 2008;74:664-673.
108. Hardy BE, Shah T, Cicciarelli J, Lemley KV, Hutchinson IV, Cho YW. Kidney transplantation in children and adolescents: an analysis of united network for organ sharing database. Transplant Proc. 2009;41: 1533-1535.
109. Tejani A, Fine R, Alexander S, Harmon W, Stablein D. Factors predictive of sustained growth in children after renal transplantation. the North American Pediatric Renal Transplant Cooperative Study. J Pediatr. 1993;122:397-402.
110. Fuqua JS. Growth after organ transplantation. Semin Pediatr Surg. 2006;15:162-169.
111. Turenne MN, Port FK, Strawderman RL, et al. Growth rates in pediatric dialysis patients and renal transplant recipients. Am J Kidney Dis. 1997;30:193-203.
112. Grenda R, Watson A, Trompeter R, et al. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. Am J Transplant. 2010;10: 828-836.
113. Klare B, Montoya CR, Fischer DC, Stangl MJ, Haffner D. Normal adult height after steroid-withdrawal within 6 months of pediatric kidney transplantation: a 20 years single center experience. Transpl Int. 2012;25:276-282.
114. Motoyama O, Hasegawa A, Aikawa A, et al. Final height in a prospective trial of late steroid withdrawal after pediatric renal transplantation treated with cyclosporine and mizoribine. Pediatr Transplant. 2012;16: 78-82.
115. Hodson EM, Willis NS, Craig JC. Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev. 2012;2: CD003264.
116. Lledo-Garcia E, Hernandez-Fernandez C, Subira-Rios D, et al. Cadaver donor kidney retransplantation in the pediatric patient: complications and long-term outcome. J Urol. 2011;185(Suppl 6):2582-2585.